米多君加速批准及可能撤市 - Suppr

Accelerated approval and possible withdrawal of midodrine.

作者信息

Dhruva Sanket S, Redberg Rita F

机构信息

UCSF School of Medicine, 505 Parnassus Ave, Ste M-1180, San Francisco, CA 94143-0124, USA.

出版信息

JAMA. 2010 Nov 17;304(19):2172-3. doi: 10.1001/jama.2010.1695.

DOI:10.1001/jama.2010.1695

PMID:21081731

Abstract

摘要

相似文献

Accelerated approval and possible withdrawal of midodrine.

JAMA. 2010 Nov 17;304(19):2172-3. doi: 10.1001/jama.2010.1695.

Withdrawing FDA approval of midodrine after marketing.

JAMA. 2011 Feb 23;305(8):781-2; author reply 782. doi: 10.1001/jama.2011.161.

FDA takes slow road toward withdrawal of drug approved with fast-track process.

JAMA. 2011 Mar 9;305(10):982, 984. doi: 10.1001/jama.2011.269.

Does $760 m a year of industry funding affect the FDA's drug approval process?

BMJ. 2014 Aug 5;349:g5012. doi: 10.1136/bmj.g5012.

Oversight of fast-track drug approval by FDA stuck in low gear, critics say.

JAMA. 2010 Oct 27;304(16):1773-5. doi: 10.1001/jama.2010.1486.

Accelerated approval of oncology products: the food and drug administration experience.

J Natl Cancer Inst. 2011 Apr 20;103(8):636-44. doi: 10.1093/jnci/djr062. Epub 2011 Mar 21.

Postmarketing surveillance and reporting of adverse drug events.

S D J Med. 2004 Jan;57(1):13-4.

Needed: an intervention. Drug industry's control of health policy must be broken.

Mod Healthc. 2004 Nov 29;34(48):18.

Takotsubo cardiomyopathy after midodrine therapy.

Tex Heart Inst J. 2012;39(1):158-9.

Drug safety. Gaps in the safety net.

Science. 2005 Jan 14;307(5707):196-8. doi: 10.1126/science.307.5707.196.

引用本文的文献

Analysis and comparative evaluation of expedited programs for gene therapy products: insights from the United States, the European Union, Japan, and South Korea.

Gene Ther. 2024 May;31(5-6):242-254. doi: 10.1038/s41434-023-00437-7. Epub 2024 Jan 10.

Midodrine use in critically ill patients: a narrative review.

Crit Care Resusc. 2023 Oct 16;24(4):298-308. doi: 10.51893/2022.4.R. eCollection 2022 Dec 5.

Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness.

Front Med (Lausanne). 2022 Feb 3;8:818647. doi: 10.3389/fmed.2021.818647. eCollection 2021.

Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson's Disease-a Systematic Review.

Curr Hypertens Rep. 2021 May 7;23(5):26. doi: 10.1007/s11906-021-01146-5.

Midodrine for orthostatic hypotension.

Aust Prescr. 2021 Feb;44(1):31. doi: 10.18773/austprescr.2020.081. Epub 2020 Dec 17.

Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.

Intensive Care Med. 2020 Oct;46(10):1884-1893. doi: 10.1007/s00134-020-06216-x. Epub 2020 Sep 3.

Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.

J Clin Hypertens (Greenwich). 2019 Sep;21(9):1308-1314. doi: 10.1111/jch.13619. Epub 2019 Aug 1.

Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).

BMC Anesthesiol. 2017 Mar 21;17(1):47. doi: 10.1186/s12871-017-0339-x.

Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union.

J Tissue Eng Regen Med. 2018 Feb;12(2):e1056-e1062. doi: 10.1002/term.2428. Epub 2017 Jun 27.

Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.

Curr Neurol Neurosci Rep. 2015 Dec;15(12):78. doi: 10.1007/s11910-015-0599-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Accelerated approval and possible withdrawal of midodrine.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献